BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11903869)

  • 1. Morphine, pethidine and buprenorphine disposition in the cat.
    Taylor PM; Robertson SA; Dixon MJ; Ruprah M; Sear JW; Lascelles BD; Waters C; Bloomfield M
    J Vet Pharmacol Ther; 2001 Dec; 24(6):391-8. PubMed ID: 11903869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of buprenorphine after intravenous administration of clinical doses to dogs.
    Andaluz A; Moll X; Abellán R; Ventura R; Carbó M; Fresno L; García F
    Vet J; 2009 Sep; 181(3):299-304. PubMed ID: 18467137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and subcutaneous buprenorphine in conscious cats.
    Steagall PV; Pelligand L; Giordano T; Auberger C; Sear JW; Luna SP; Taylor PM
    Vet Anaesth Analg; 2013 Jan; 40(1):83-95. PubMed ID: 22998333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of buprenorphine following intravenous administration in dogs.
    Krotscheck U; Boothe DM; Little AA
    Am J Vet Res; 2008 Jun; 69(6):722-7. PubMed ID: 18518651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of intravenous and intramuscular buprenorphine in the horse.
    Davis JL; Messenger KM; LaFevers DH; Barlow BM; Posner LP
    J Vet Pharmacol Ther; 2012 Feb; 35(1):52-8. PubMed ID: 21392040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of oral morphine sulfate in dogs: a comparison of sustained release and conventional formulations.
    Dohoo SE; Tasker RA
    Can J Vet Res; 1997 Oct; 61(4):251-5. PubMed ID: 9342447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic uptake of buprenorphine by cats after oral mucosal administration.
    Robertson SA; Taylor PM; Sear JW
    Vet Rec; 2003 May; 152(22):675-8. PubMed ID: 12803393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetics of intravenous fentanyl and buprenorphine in healthy greyhound dogs.
    KuKanich B; Allen P
    J Vet Pharmacol Ther; 2014 Dec; 37(6):595-7. PubMed ID: 24684621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of buprenorphine after intravenous administration in the mouse.
    Yu S; Zhang X; Sun Y; Peng Y; Johnson J; Mandrell T; Shukla AJ; Laizure SC
    J Am Assoc Lab Anim Sci; 2006 May; 45(3):12-6. PubMed ID: 16642964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of buprenorphine in healthy, lactating goats.
    Ingvast-Larsson C; Svartberg K; Hydbring-Sandberg E; Bondesson U; Olsson K
    J Vet Pharmacol Ther; 2007 Jun; 30(3):249-56. PubMed ID: 17472657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of pethidine in pigs following intravenous, intramuscular and subcutaneous administration.
    Ranheim B; Høiset J; Framstad T; Horsberg TE; Skaare JU; Søli NE
    J Vet Pharmacol Ther; 1998 Dec; 21(6):491-3. PubMed ID: 9885972
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of buprenorphine following intravenous and intramuscular administration in male rhesus macaques (Macaca mulatta).
    Kelly KR; Pypendop BH; Christe KL
    J Vet Pharmacol Ther; 2014 Oct; 37(5):480-5. PubMed ID: 24666428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of morphine and plasma concentrations of morphine-6-glucuronide following morphine administration to dogs.
    KuKanich B; Lascelles BD; Papich MG
    J Vet Pharmacol Ther; 2005 Aug; 28(4):371-6. PubMed ID: 16050817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of buprenorphine following intravenous and buccal administration in cats, and effects on thermal threshold.
    Hedges AR; Pypendop BH; Shilo-Benjamini Y; Stanley SD; Ilkiw JE
    J Vet Pharmacol Ther; 2014 Jun; 37(3):252-9. PubMed ID: 24862514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of epidural morphine and meperidine in humans.
    Sjöström S; Hartvig P; Persson MP; Tamsen A
    Anesthesiology; 1987 Dec; 67(6):877-88. PubMed ID: 2891328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of buprenorphine following intravenous and oral transmucosal administration in dogs.
    Abbo LA; Ko JC; Maxwell LK; Galinsky RE; Moody DE; Johnson BM; Fang WB
    Vet Ther; 2008; 9(2):83-93. PubMed ID: 18597246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of morphine in combination with dexmedetomidine and maropitant following intramuscular injection in dogs anaesthetized with halothane.
    Karna SR; Singh P; Chambers P; Kongara K
    J Vet Pharmacol Ther; 2020 Mar; 43(2):153-161. PubMed ID: 31856324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of clinical hepatic disease on the distribution and elimination of pethidine administered post-operatively to dogs.
    Waterman AE; Kalthum W
    J Vet Pharmacol Ther; 1990 Jun; 13(2):137-47. PubMed ID: 2384904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, pharmacodynamics, and analgesic effects of morphine after rectal, intramuscular, and intravenous administration in dogs.
    Barnhart MD; Hubbell JA; Muir WW; Sams RA; Bednarski RM
    Am J Vet Res; 2000 Jan; 61(1):24-8. PubMed ID: 10630773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PK-PD modeling of buprenorphine in cats: intravenous and oral transmucosal administration.
    Robertson SA; Lascelles BD; Taylor PM; Sear JW
    J Vet Pharmacol Ther; 2005 Oct; 28(5):453-60. PubMed ID: 16207308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.